Targeting STAT3 signaling to promote recovery from neuropathic pain
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210685
- Recipient
-
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16 Part of University Of Texas System
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $871,203
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Houston, TX 77030, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $871,203 Project Grant to The University of Texas M.D. Anderson Cancer Center on August 15, 2022 through the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research targeting STAT3 signaling pathways to promote recovery from neuropathic pain. Dr. Heijnen of William Marsh Rice University will provide expertise in immunology aspects of the project through overseeing experiments, advising on experimental design and statistical analysis, and assisting with manuscript preparation. The sub-award to Rice University will support immunology-focused contributions to the research aimed at developing medical solutions for battlefield injuries and transforming veterans' healthcare.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| William Marsh Rice University | $11,285 |
Quick answers
Who received award W81XWH2210685?
W81XWH2210685 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by Medical Command (Department of the Army) on August 15, 2022.
How much is award W81XWH2210685 worth?
$871,203 has been obligated on W81XWH2210685.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award